CAS: 2555-37-5 - 3-acetyl-4-hydroxy-2-benzopyrone
Formula:C11H8O4
InChI:InChI=1S/C11H8O4/c1-6(12)9-10(13)7-4-2-3-5-8(7)15-11(9)14/h2-5,13H,1H3
InChI key:InChIKey=UTZHUXAPJIBIBQ-UHFFFAOYSA-N
SMILES:O=C1OC=2C=CC=CC2C(O)=C1C(=O)C
- Synonyms:
- 2H-1-Benzopyran-2-one, 3-acetyl-4-hydroxy-
- 3-Acetyl-4-hydroxy-2H-1-benzopyran-2-one
- 3-Acetyl-4-hydroxychromen-2-one
- 3-Acetyl-4-hydroxycoumarin
- 3-acetyl-2-hydroxy-4H-chromen-4-one
- 3-acetyl-4-hydroxy-2H-chromen-2-one
- 4-Hydroxy-3-acetylcoumarin
- Coumarin, 3-acetyl-4-hydroxy-
- Nsc 11840
3-Acetyl-4-hydroxy-2H-chromen-2-one
CAS:2555-37-5
Formula:
C11H8O4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
204.1788
Ref: IN-DA006U18
1g | 155.00 € | ||
5g | To inquire | ||
100mg | 68.00 € | ||
250mg | 108.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 4Z-C-1621
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Ref: 10-F369187
1g | 172.00 € | ||
5g | 476.00 € | ||
250mg | 76.00 € |
Estimated delivery in United States, on Friday 20 Dec 2024
3-Acetyl-4-hydroxy-2H-chromen-2-one
CAS:2555-37-5
3-Acetyl-4-hydroxy-2H-chromen-2-one is a potent inhibitor of human lipoxygenase and soybean lipoxygenase. This compound has been …
Formula:
C11H8O4
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
204.18 g/mol
Ref: 3D-FA121787
1g | 454.00 € | ||
2g | 669.00 € | ||
5g | 1,125.00 € | ||
250mg | 272.00 € | ||
500mg | 410.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
3-Acetyl-4-hydroxycoumarin
Controlled ProductCAS:2555-37-5
Formula:
C11H8O4
Color and Shape:
Neat
Molecular weight:
204.18
Ref: TR-A179175
50mg | 253.00 € | ||
100mg | 447.00 € | ||
500mg | 1,727.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
3-Acetyl-4-hydroxycoumarin-d4
Controlled ProductCAS:2555-37-5
Formula:
C11D4H4O4
Color and Shape:
Neat
Molecular weight:
208.203
Ref: TR-A179177
100mg | 3,568.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025